IQVIA Pharma Deals Review
ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.
Pharma Deals Review Latest Articles
-
Novartis Pays Arvinas US$150 M Upfront for Prostate Cancer Protein Degrader
-
Vertex Buys Alpine Immune Sciences and its Kidney Disease Drug for US$4.9 B
-
Genmab Acquires ADC Drug Developer ProfoundBio for US$1.8 B
-
IQVIA Pharma Deals Review of 2023
-
Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs
You can click on any of the bars to open a new page with the corresponding deals.